Uvax Bio To Invest $8M, Expand In Delaware

SourceBusinessf Facilities
Date Published10/25/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Uvax Bio
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):63
Year reshoring announced:2022
City reshored to:Newark
State(s) reshored to:DE
If relevant, work nearshored to:-
Product(s) reshoredCOVID-19 and HIV-1 vaccine
What domestic positive factors made reshoring more attractive?Government Incentives, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training, Under-utilized capacity
Find Reshoring Articles